Pharma Companies Develop Counter-Strategy To Insurers’ Tactic Of Moving Patients Away From Expensive Drugs

Insurers are making patients pay a higher portion of the pricey drugs' costs, but pharmaceutical companies are parrying that move by dramatically raising the financial aid they offer, in the form of "copay assistance" cards.

More From BioPortfolio on "Pharma Companies Develop Counter-Strategy To Insurers’ Tactic Of Moving Patients Away From Expensive Drugs"